Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Articles tagged with "REF News"

Chance Discovery May Provide RA Diagnostic

Sue Pondrom  |  November 1, 2009

Science From Arthritis & Rheumatism

Within Our Reach–Funded Research May Hold Key to Unlocking the CNS and Suppressing RA

Staff  |  November 1, 2009

Studies recently published in Arthritis & Rheumatism show that a key chemical produced by the central nervous system (CNS) decreases inflammation and suppresses production of proteins known to play a role in rheumatoid arthritis (RA). This opens the way for developing a novel class of drugs that mimic this effect of the CNS on RA.

Within Our Reach Investigators’ Meeting Brings Together Junior and Senior Investigators

Soumya Raychaudhuri, MD, PhD  |  October 1, 2009

The Within Our Reach Investigators’ Meeting, held in San Diego in June, was an incredible gathering of researchers funded through the ACR Research and Education Foundation’s (REF’s) Within Our Reach: Finding a Cure for Rheumatoid Arthritis campaign. The focus on rheumatoid arthritis (RA) was unmistakable as investigators from around the country presented work ranging from very basic immunology to health outcomes. 

Building a Sustainable Foundation

Leslie J. Crofford, MD  |  September 1, 2009

A look back at my time serving the ACR and the REF

Our Interdisciplinary Outlook

Sherine Gabriel, MD, and Pamela Degotardi, PhD  |  September 1, 2009

Rheumatologists and health professionals working together is one of our great strengths

Within Our Reach–Funded Research Finds Highly Specific Markers of RA

Staff  |  August 1, 2009

A study recently published in Arthritis & Rheumatism concluded that anti–peptidyl arginine deiminase type 4 (PAD-4) antibodies are highly specific markers of RA and appear to be useful markers of disease severity. The project studied an important and previously unrecognized immune response in RA—anti–PAD-4, which is one of the major proteins that creates other common autoantigens in RA.

Productive Partnership

Sherine Gabriel, MD, and Leslie J. Crofford, MD  |  August 1, 2009

The ACR and the REF work closely to support the future of rheumatology

Closer to a Cure

Staff  |  July 1, 2009

Over the last two years, the Within Our Reach: Finding a Cure for Rheumatoid Arthritis campaign has granted almost $9 million to 30 researchers in the hopes of finding a cure for rheumatoid arthritis (RA). These researchers are studying an array of issues, from innovative research into the genetics of RA to new treatments that will more effectively manage the disease. With the REF’s announcement of the third round of Within Our Reach grant recipients, patients with RA are closer to a cure.

We Are All in This Together

Leslie Crofford, MD  |  June 1, 2009

While rheumatologists in private practice face daily concerns regarding reimbursements and certifications, the Research and Education Foundation (REF) is working behind the scenes to help improve patients’ lives. Through its balanced core awards and grants portfolio, the REF supports education, training, and career development for the future academic workforce.

Streamlined Funding Portfolio Increases Efficacy

Staff  |  May 1, 2009

The ACR Research and Education Foundation recently completed a comprehensive review of its core awards and grants portfolio to assure that it was effective in meeting the needs of junior or early career physician-scientists and health professionals.

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 8
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences